HELSINKI, Sept. 18, 2020 /PRNewswire/ -- Optomed and AEYE Health have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE. The collaboration includes a ...

May 1 (Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its ...

Optomed USA has launched Optomed Aurora AEYE, a handheld AI fundus camera designed to instantly detect more than mild diabetic retinopathy. Developed in collaboration with AEYE Health, the device ...

December 5, 2019 – Nasdaq (Nasdaq: NDAQ) announced that trading in Optomed Plc shares (short name: OPTOMED) commence today on the prelist of Nasdaq Helsinki. Optomed is a small cap company within the ...

Based on the one-year price targets offered by three analysts, the average target price for Optomed PLC (OHEL:OPTOMED) is $4.67, with a high estimate of $5.00 and a low estimate of $4.00. The average ...

HELSINKI, Jan. 28, 2021 /PRNewswire/ -- Optomed has established an international scientific advisory board. The board consists of globally recognized and scientifically merited medical doctors ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Optomed is a Finnish medical technology company that specializes in retinal imaging devices and solutions. The company's products are used for screening, diagnosis, and follow-up of various eye ...

In a procedure that takes a minute, the device takes images from each eye using a special camera and through artificial intelligence captures and analyses data on the retina to help diagnose diseases ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.